Advertisement

Pharmacotherapy of Insomnia

  • Edward J. Stepanski
  • Frank J. Zorick
  • Thomas Roth
Part of the Critical Issues in Psychiatry book series (CIPS)

Abstract

For the purposes of this chapter, “hypnotic medication” is synonymous with “benzodiazepine sedative—hypnotics.” In our opinion, there is almost never an indication to use an older, nonbenzodiazepine hypnotic (e.g., barbiturates, chloral hydrate, glutethimide, meprobamate) for the treatment of insomnia. In situations where depression or nonrestorative sleep syndrome (alpha—delta sleep) is present, the use of a sedating tricyclic antidepressant may be indicated. This will be discussed later.

Keywords

Anxiety Disorder Sleep Disorder Borderline Personality Disorder Sleep Hygiene Chronic Insomnia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Recommended Readings

  1. Greenblatt, D. J., Shader, R. I., Divoll, M., Harmatz, J. S. (1981). Benzodiazepines: A summary of pharmokinetic properties. British Journal of Clinical Pharmacology, 11, 11S - 16S. This paper describes the pharmokinetics of various benzodiazepine medications. Special emphasis is given to single-dose effects as opposed to multiple-dose effects, and the specific differences between drugs are discussed.Google Scholar
  2. Nicholson, A. N. (1989). Hypnotics: Clinical pharmacology and therapeutics. In M. H. Kryger, T. Roth, W. C. Dement (Eds.), Principles and practice of sleep medicine. Philadelphia: W. B. Saunders, pp. 219–228. This chapter provides a description of the relevant pharmacology of hypnotic drugs. It also provides detailed summaries of the individual differences between various hypnotic medications. Finally, there are recommendations on the appropriate clinical use of these drugs.Google Scholar
  3. Woods, J. H., Katz, J. L., Winger, G. (1988). Use and abuse of benzodiazepines: Issues relevant to prescribing. Journal of the American Medical Association, 260(23), 3476–3480. This paper reviews the literature in regard to potential dependence with benzodiazepine use. Adverse effects are also discussed.Google Scholar

References

  1. Bornstein, P., Cujo, P. (1974). Influence of barbiturates and benzodiazepines on the sleep EEG. In T. M. Itil, (Ed.), Psychotropic drugs and the human EEG. Modern problems of pharmacopsychiatry (Vol. 8 ). Basel: Karger, pp. 182–192.Google Scholar
  2. Greenblatt, D. J. (1980). Pharmacokinetic comparisons. Psychosomatics, 21 (10), 9–14.PubMedGoogle Scholar
  3. Greenblatt, D., Shader, R., Divoll, M., Harmatz, J. (1981). Benzodiazepines: A summary of pharmacokinetic properties. British Journal of Clinical Pharmacology, 11, 11S - 16S.PubMedCrossRefGoogle Scholar
  4. Johnson, L. C., Chernik, D. A. (1982). Sedative-hypnotics and human performance. Psychopharmacology, 76, 101–114.PubMedCrossRefGoogle Scholar
  5. Kales, A., Kales, J. D., Bixler, E. O., Scharf, M. B. (1975). Effectiveness of hypnotic drugs with prolonged use: Flurazepam and pentobarbital. Clinical Pharmacology and Therapeutics, 18, 356–363.PubMedGoogle Scholar
  6. Moskowitz, H., Smiley, A. (1982). Effects of chronically administered buspirone and diazepam on driving-related skills performance. Journal of Clinical Psychiatry, 43 (12), 45–55.PubMedGoogle Scholar
  7. National Institute of Mental Health, Consensus Development Conference. (1984). Drugs and insomnia: The use of medications to promote sleep. Journal of the American Medical Association, 251, 2410–2414.Google Scholar
  8. Nicholson, A. N. (1981). The use of short-and long-acting hypnotics in clinical medicine. British Journal of Clinical Pharmacology, 11, 61S - 69S.PubMedCrossRefGoogle Scholar
  9. Oswald, I., French, C., Adam, K., Gilham, J. (1982). Benzodiazepine hypnotics remain effective for 24 weeks. British Medical Journal, 284, 860–863.PubMedCrossRefGoogle Scholar
  10. Perkins, R., Hinton, J. (1974). Sedative or tranquilizer? A comparison of the hypnotic effects of chlordiazepoxide and amylobarbitone sodium. British Journal of Psychiatry, 124, 435–439.PubMedCrossRefGoogle Scholar
  11. Roehrs, T., Kribbs, N., Zorick, E, Roth, T (1986). Hypnotic residual effects of benzodiazepines with repeated administration. Sleep, 9 (2), 309–316.PubMedGoogle Scholar
  12. Roehrs, T., Vogel, G., Wittig, R., Zorick, F., Paxton, C., Lamphere, J., Roth, T. (1986). Dose effects of temazepam tablets on sleep. Drugs in Experimental Clinical Research, 12(8), 693–699.Google Scholar
  13. Roehrs, T., Zorick, E, Sicklesteel, J., Wittig, R., Hartse, K., Roth, T. (1983). Effects of hypnotics on memory. Journal of Clinical Pharmacology, 3 (5), 310–313.Google Scholar
  14. Roth, T., Hartse, K. M., Saab, P. G., Piccione, P. M., Kramer, M. (1980). The effects of flurazepam, lorazepam, and triazolam on sleep and memory. Psychopharmacology, 70, 231–237.PubMedCrossRefGoogle Scholar
  15. Stepanski, E., Zorick, E, Kaffeman, M., Sicklesteel, J., Roth, T. (1982). Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs. Nouvelle Presse Médicale, 11, 2987–2990.PubMedGoogle Scholar
  16. Veldkamp, W., Straw, R. N., Metzler, C. M., Demissianos, H. V. (1974). Efficacy and residual effect evaluation of a new hypnotic, triazolam. Journal of Clinical Pharmacology, 14, 102–111.PubMedCrossRefGoogle Scholar
  17. Vogel, G. W, Barker, K., Gibbons, P., Thurmond, A. (1976). A comparison of the effects of flurazepam 30 mgs and triazolam 0.5 mgs on the sleep of insomniacs. Psychopharmacologia, 47, 81–86.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Edward J. Stepanski
    • 1
  • Frank J. Zorick
    • 1
  • Thomas Roth
    • 1
  1. 1.Sleep Disorders and Research CenterHenry Ford HospitalDetroitUSA

Personalised recommendations